Credit Suisse’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$1.06M Buy
76,922
+1,722
+2% +$26.9K ﹤0.01% 2223
2023
Q4
$1.46M Buy
75,200
+9,240
+14% +$171K ﹤0.01% 2095
2023
Q3
$1.4M Sell
65,960
-2,335
-3% -$60.7K ﹤0.01% 2056
2023
Q2
$2.27M Buy
68,295
+24,130
+55% +$888K ﹤0.01% 1829
2023
Q1
$1.74M Buy
44,165
+2,295
+5% +$95.4K ﹤0.01% 1965
2022
Q4
$1.77M Sell
41,870
-2,073
-5% -$79.8K ﹤0.01% 1957
2022
Q3
$1.47M Buy
43,943
+472
+1% +$19.7K ﹤0.01% 2052
2022
Q2
$1.88M Sell
43,471
-3,714
-8% -$170K ﹤0.01% 1961
2022
Q1
$2.26M Sell
47,185
-6,337
-12% -$314K ﹤0.01% 1996
2021
Q4
$2.72M Sell
53,522
-785
-1% -$34.9K ﹤0.01% 2543
2021
Q3
$2.2M Buy
54,307
+6,391
+13% +$323K ﹤0.01% 2744
2021
Q2
$2.72M Sell
47,916
-22,618
-32% -$1.29M ﹤0.01% 2606
2021
Q1
$3.73M Sell
70,534
-20,314
-22% -$1.11M ﹤0.01% 2316
2020
Q4
$4.96M Buy
90,848
+30,421
+50% +$1.6M ﹤0.01% 2095
2020
Q3
$3.03M Sell
60,427
-4,443
-7% -$211K ﹤0.01% 2121
2020
Q2
$2.48M Sell
64,870
-80,202
-55% -$2.58M ﹤0.01% 2213
2020
Q1
$3.17M Buy
145,072
+65,280
+82% +$1.96M ﹤0.01% 1806
2019
Q4
$3.27M Sell
79,792
-13,059
-14% -$533K ﹤0.01% 2210
2019
Q3
$3.95M Buy
92,851
+47,609
+105% +$2M ﹤0.01% 1950
2019
Q2
$2.23M Sell
45,242
-52,666
-54% -$2.68M ﹤0.01% 2383
2019
Q1
$4.69M Sell
97,908
-67,418
-41% -$4.09M ﹤0.01% 1757
2018
Q4
$10.1M Buy
165,326
+80,821
+96% +$5.45M 0.01% 1142
2018
Q3
$6.96M Sell
84,505
-89,511
-51% -$7.11M 0.01% 1488
2018
Q2
$13.6M Buy
174,016
+97,291
+127% +$7.54M 0.01% 1064
2018
Q1
$5.66M Buy
76,725
+1,974
+3% +$140K 0.01% 1636
2017
Q4
$5.1M Buy
74,751
+11,296
+18% +$731K ﹤0.01% 1771
2017
Q3
$3.9M Sell
63,455
-8,114
-11% -$498K ﹤0.01% 1966
2017
Q2
$4.5M Sell
71,569
-50,647
-41% -$2.89M ﹤0.01% 1693
2017
Q1
$6.79M Buy
122,216
+48,082
+65% +$2.48M 0.01% 1436
2016
Q4
$3.54M Sell
74,134
-126,855
-63% -$7.11M ﹤0.01% 1931
2016
Q3
$13M Buy
200,989
+36,014
+22% +$2.02M 0.01% 1037
2016
Q2
$7.62M Sell
164,975
-5,707
-3% -$230K 0.01% 1350
2016
Q1
$6.53M Sell
170,682
-6,277
-4% -$208K 0.01% 1359
2015
Q4
$6.71M Sell
176,959
-3,844
-2% -$142K 0.01% 1385
2015
Q3
$7.46M Sell
180,803
-31,454
-15% -$1.35M 0.01% 1303
2015
Q2
$10M Buy
212,257
+36,017
+20% +$1.95M 0.01% 1246
2015
Q1
$10.6M Buy
176,240
+14,894
+9% +$758K 0.01% 1162
2014
Q4
$7.05M Buy
161,346
+4,763
+3% +$210K 0.01% 1512
2014
Q3
$7.05M Buy
156,583
+17,839
+13% +$949K 0.01% 1507
2014
Q2
$10.3M Sell
138,744
-45,208
-25% -$3.56M 0.01% 1380
2014
Q1
$15.2M Buy
183,952
+34,818
+23% +$3.06M 0.01% 981
2013
Q4
$20.6M Buy
149,134
+12,787
+9% +$1.51M 0.02% 817
2013
Q3
$13.1M Buy
136,347
+38,300
+39% +$3.25M 0.01% 983
2013
Q2
$5.99M Buy
+98,047
New +$5.44M 0.01% 1437

Other funds holding NUS

Credit Suisse's NUS Position: Q1 2024 in Review

Credit Suisse increased its Nu Skin (NUS) stake by 2.3% in Q1 2024, buying an estimated $26.9K and bringing the position to 76,922 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2223.

Credit Suisse first reported a position in NUS in Q2 2013 and has held it in 44 quarters since. The position peaked at $20.6M in Q4 2013. 198 funds tracked by Wall St. Rank hold NUS as of Q1 2024.

  • Credit Suisse held 76,922 shares of Nu Skin worth $1.06M as of Q1 2024.
  • Credit Suisse bought 1,722 Nu Skin shares in Q1 2024, an estimated $26.9K.
  • Nu Skin made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2223 holding.
  • Credit Suisse first reported a position in Nu Skin in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Nu Skin position peaked at $20.6M in Q4 2013.
  • 198 funds tracked by Wall St. Rank held Nu Skin as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.